InvestorsHub Logo
Followers 196
Posts 24676
Boards Moderated 0
Alias Born 04/03/2010

Re: danielboog2 post# 390461

Tuesday, 07/20/2021 4:00:08 PM

Tuesday, July 20, 2021 4:00:08 PM

Post# of 700708
I don't think that is the issue.

It is not primarily NWBO's executive team or others handling the analysis but more likely UCLA/Dr. Liau and others who are reviewing on the clinical teams from trial centers, so I don't think that will be or is the likely problem. They have lots of other experts advising as well, including likely members of the SAB.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News